{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:26:41Z","timestamp":1794317201805,"version":"4.9.0"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:p>We report the challenging diagnosis of an 11-year-old boy, presenting with subacute erythroblastopenia, followed by a multisystemic immune-mediated syndrome characterized by polymorphic mucocutaneous manifestations, associated with severe myositis related to a dermatomyositis-like phenotype and mild hepatitis. A progressive lymphadenopathy led to a delayed diagnosis of T-lymphoblastic lymphoma associated with paraneoplastic autoimmune multiorgan syndrome. To achieve remission of this paraneoplastic syndrome, Janus kinase inhibitor was required in addition to antitumor therapy. This case highlights several key points: (1) Pediatricians should consider a paraneoplastic origin when facing juvenile dermatomyositis with atypical features, such as hematologic and mucosal abnormalities; (2) in uncertain cases, early collaboration with oncologists is needed to optimize diagnostic and therapeutic strategies; (3) the choice of immunomodulatory therapy is critical in addition to antitumor therapy.<\/jats:p>","DOI":"10.1542\/peds.2025-073912","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:02:36Z","timestamp":1792454556000},"source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Autoimmune Multiorgan Syndrome: Diagnostic Lessons for Pediatricians"],"prefix":"10.1542","volume":"158","author":[{"given":"Bilade","family":"Cherqaoui","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Ambroise Par\u00e9 Hospital, AP-HP, Boulogne-Billancourt, France"},{"name":"2Infection & Inflammation, UMR1173, INSERM, University of Paris Saclay, Montigny-le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Jaume","sequence":"additional","affiliation":[{"name":"3Department of Pediatric Dermatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France"},{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Schleiermacher","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"5SIREDO Integrated Pediatric Oncology Center, Curie Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lesage","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"6Department of Pediatric Intensive Care, Necker-Enfants Malades Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Drummond","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"7Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Drabent","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"8Department of Pathology, Necker-Enfants Malades Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-J\u00e9r\u00f4me","family":"Authier","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"9Department of Pathology, Reference Center for Neuromuscular Rare Diseases, Henri Mondor Hospital, AP-HP, INSERM U955 Team Relaix, Paris Est-Cr\u00e9teil University, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klervie","family":"Loiselet","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"10Department of Pediatric Radiology, Necker-Enfants Malades Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris-Cit\u00e9, Paris, France"},{"name":"11Department of Pediatric Immunology, Hematology and Rheumatology, Reference Center for Rheumatic, Autoimmune, Inflammatory Systemic Diseases in Children (RAISE), Necker-Enfants Malades Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"17","key":"2026111007522619900_r1","doi-asserted-by":"crossref","first-page":"e147898","DOI":"10.1172\/JCI147898","article-title":"Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia","volume":"131","author":"Li","year":"2021","journal-title":"J Clin Invest."},{"issue":"6","key":"2026111007522619900_r2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3324\/haematol.2019.238766","article-title":"Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target","volume":"106","author":"Larose","year":"2021","journal-title":"Haematologica."},{"issue":"suppl 1","key":"2026111007522619900_r3","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood-2024-205327","article-title":"How to administer pegaspargase during induction treatment of acute lymphoblastic leukemia in children and adolescents? Results of the Caall-F01, a multicentre randomized clinical trial from the French Pediatric Cancer Society (SFCE)","volume":"144","author":"Strullu","year":"2024","journal-title":"Blood."},{"issue":"6","key":"2026111007522619900_r4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41584-023-00967-9","article-title":"Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care","volume":"19","author":"Papadopoulou","year":"2023","journal-title":"Nat Rev Rheumatol."},{"issue":"12","key":"2026111007522619900_r5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/14656566.2024.2392021","article-title":"Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons","volume":"25","author":"Wallwork","year":"2024","journal-title":"Expert Opin Pharmacother."},{"issue":"9408","key":"2026111007522619900_r6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman\u2019s tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet."},{"issue":"4","key":"2026111007522619900_r7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/ijd.12603","article-title":"Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients","volume":"54","author":"Lehman","year":"2015","journal-title":"Int J Dermatol."},{"issue":"4","key":"2026111007522619900_r8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol."},{"issue":"25","key":"2026111007522619900_r9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med."},{"issue":"4","key":"2026111007522619900_r10","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1542\/peds.2004-0436","article-title":"Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature","volume":"114","author":"Lane","year":"2004","journal-title":"Pediatrics."},{"issue":"6","key":"2026111007522619900_r11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"12","key":"2026111007522619900_r12","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/PAS.0000000000001158","article-title":"Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome","volume":"42","author":"Walters","year":"2018","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"2026111007522619900_r13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pde.15138","article-title":"Paraneoplastic pemphigus associated with Castleman disease: a multicenter case series","volume":"40","author":"Barry","year":"2023","journal-title":"Pediatr Dermatol."},{"key":"2026111007522619900_r14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jns.2016.08.060","article-title":"Inflammatory myopathies and lymphoma","volume":"369","author":"St\u00fcbgen","year":"2016","journal-title":"J Neurol Sci."},{"issue":"4","key":"2026111007522619900_r15","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/curroncol29040194","article-title":"Antibody-negative paraneoplastic autoimmune multiorgan syndrome (PAMS) in a patient with follicular lymphoma accompanied by an excess of peripheral blood CD8+ lymphocytes","volume":"29","author":"Gambichler","year":"2022","journal-title":"Curr Oncol."},{"issue":"9","key":"2026111007522619900_r16","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/1756-185X.14684","article-title":"Paraneoplastic pemphigus misdiagnosed as juvenile dermatomyositis: a case report","volume":"26","author":"Gao","year":"2023","journal-title":"Int J Rheum Dis."},{"issue":"6","key":"2026111007522619900_r17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med."},{"issue":"1","key":"2026111007522619900_r18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"2026111007522619900_r19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar4198","article-title":"Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?","volume":"15","author":"Tansley","year":"2013","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"2026111007522619900_r20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br J Dermatol."},{"issue":"12","key":"2026111007522619900_r21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"2026111007522619900_r22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2017.03.033","article-title":"Juvenile dermatomyositis\/polymyositis and lymphoma","volume":"377","author":"St\u00fcbgen","year":"2017","journal-title":"J Neurol Sci."},{"issue":"6","key":"2026111007522619900_r23","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/rheumatology\/keab922","article-title":"A 10-year-old girl with low-grade B cell lymphoma complicated by anti-nuclear matrix protein 2 autoantibody-positive juvenile dermatomyositis","volume":"61","author":"Kobayashi","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"11","key":"2026111007522619900_r24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/ped.14334","article-title":"Paraneoplastic dermatomyositis with pediatric Hodgkin lymphoma: a case report","volume":"62","author":"Yoshimoto Suzuki","year":"2020","journal-title":"Pediatr Int."},{"issue":"4","key":"2026111007522619900_r25","first-page":"744","article-title":"A child with dermatomyositis and a suspicious lymphadenopathy","volume":"32","author":"Martini","year":"2005","journal-title":"J Rheumatol."},{"issue":"3","key":"2026111007522619900_r26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-021-05992-1","article-title":"Eyelid erythema as the first manifestation of subcutaneous panniculitis-like T-cell lymphoma mimicking dermatomyositis: a case-based review","volume":"41","author":"Sun","year":"2022","journal-title":"Clin Rheumatol."},{"issue":"10","key":"2026111007522619900_r27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0248-8663(01)00456-8","article-title":"Juvenile dermatomyositis and panniculitis-type subcutaneous T-cell lymphoma. A case report","volume":"22","author":"Laraki","year":"2001","journal-title":"Rev Med Interne."},{"issue":"3","key":"2026111007522619900_r28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a paraneoplastic phenomenon: an update","volume":"32","author":"Morris","year":"2010","journal-title":"J Pediatr Hematol Oncol."},{"issue":"6","key":"2026111007522619900_r29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.revmed.2020.02.015","article-title":"Severe MDA5 dermatomyositis associated with cancer and controlled by JAK inhibitor","volume":"41","author":"Jalles","year":"2020","journal-title":"Rev Med Interne."},{"issue":"1","key":"2026111007522619900_r30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mrcr\/rxae060","article-title":"Successful treatment of anti-melanoma differentiation-associated gene 5 (MDA-5) antibody-positive dermatomyositis with rapidly progressive interstitial lung disease complicated by bilateral breast cancer following the additional tofacitinib: a case report","volume":"9","author":"Yamane","year":"2025","journal-title":"Mod Rheumatol Case Rep."},{"issue":"3","key":"2026111007522619900_r31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat Rev Rheumatol."},{"issue":"2","key":"2026111007522619900_r32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story","volume":"83","author":"Bonelli","year":"2024","journal-title":"Ann Rheum Dis."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-073912\/1978922\/pediatrics.2025073912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-073912\/1978922\/pediatrics.2025073912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:52:36Z","timestamp":1794315156000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/158\/5\/e2025073912\/211007\/Paraneoplastic-Autoimmune-Multiorgan-Syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-073912","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"e2025073912"}}